MentionFox
Home › funding signals › 10x Science
Accelerator · announced

10x Science (YC W26) — The AI-native platform for next-generation protein characterization

10x Science develops frontier AI models with deep memory to redefine how scientists understand and engineer biology across the life sciences, starting with drug development. AI-powered drug discovery is flooding the pipeline with new candidates faster than ever.

10x Science is a Y Combinator company in the Winter 2026 batch. Its directory entry describes it as: The AI-native platform for next-generation protein characterization. The founders listed are David Roberts (Founder/CEO), Andrew Reiter (Founder/COO), Vishnu Tejus (Founder/CTO) (Y Combinator directory entry, January 13, 2026).

6 more companies from YC Winter 2026 ↓

Run the free check on 10x Science →

Sell to companies like 10x Science? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

10x Science

New accelerator entry · 2026-01-13 · the record

Winter 2026
batch
5
people
Early
stage
United States of America
region
Open the record →

What the record says

BatchWinter 2026
Announced2026-01-13
StageEarly
StatusActive
Team size5
IndustryB2B
Sub-industryB2B
SectorsSaaS, B2B, Biotech, AI
RegionsUnited States of America, America / Canada, Remote, Partly Remote
BasedSan Francisco, CA, USA
HiringYes
Sitehttps://10xscience.com

Pitching, partnering or investing alongside them? See who really runs and owns 10x Science.

Free to see. No signup.

Keep reading

More on 10x Science and the records around it.

Also in YC Winter 2026

Same batch, B2B first.

What do you want to do with 10x Science?

Get the full cited report on 10x Science

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on 10x Science: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

In their words

10x Science develops frontier AI models with deep memory to redefine how scientists understand and engineer biology across the life sciences, starting with drug development. AI-powered drug discovery is flooding the pipeline with new candidates faster than ever. But before any of them can advance to the clinic, scientists must deeply characterize the protein therapeutic to understand whether it will work. Today, that process takes months of manual, error-prone analysis that cannot keep pace with discovery. Our AI-native platform automates it, giving drug developers the confidence to advance the right candidates and stop the wrong ones early. We have strong commercial traction with enterprise pharma customers. Our founding team built the field of next-generation protein characterization out of Carolyn Bertozzi's Nobel laureate lab at Stanford. Collectively, we have 18+ years of collective domain expertise, 47+ scientific publications, and a 2x YC Founder. We move at the highest velocity and are positioned to lead the next generation of modern AI development in the life sciences.

Want the whole picture on 10x Science?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on 10x Science: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on 10x Science covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind 10x Science: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

RSS

Tools for this story

Each opens in a new tab, filled in for 10x Science. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups Drug discovery startups

Share this page

Is this your company?

Share the news. Sharing needs no account.

10x Science: Accepted into Y Combinator Winter 2026
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-10x-science
Last updated 2026-10-20
Primary record: Y Combinator directory entry
10x Science (YC W26) — The AI-native platform for next-generation protein characterization. MentionFox, 2026-10-20. https://mentionfox.com/funding/yc-10x-science